Breaking News
Grand Theft World Podcast 273 | Goys 'R U.S. with Guest Rob Dew
Anchorage was the Receipt: Europe is Paying the Price… and Knows it.
The Slow Epstein Earthquake: The Rupture Between the People and the Elites
Israeli Prime Minister, Netanyahu will meet with Trump on Wednesday and deliver instructions...
Top Tech News
Drone-launching underwater drone hitches a ride on ship and sub hulls
Humanoid Robots Get "Brains" As Dual-Use Fears Mount
SpaceX Authorized to Increase High Speed Internet Download Speeds 5X Through 2026
Space AI is the Key to the Technological Singularity
Velocitor X-1 eVTOL could be beating the traffic in just a year
Starlink smasher? China claims world's best high-powered microwave weapon
Wood scraps turn 'useless' desert sand into concrete
Let's Do a Detailed Review of Zorin -- Is This Good for Ex-Windows Users?
The World's First Sodium-Ion Battery EV Is A Winter Range Monster
China's CATL 5C Battery Breakthrough will Make Most Combustion Engine Vehicles OBSOLETE
Flourescent biotechnology for high lighting solid cancer for more complete surgical removal
.... On Target Laboratories LLC is working to advance its revolutionary fluorescent imaging technology that could help surgeons pinpoint and remove more cancerous tissues than has ever been possible while preserving more healthy tissue for patients.
Headquartered at Purdue Research Park of West Lafayette, the company is developing a series of molecules, which, when administered intravenously, show promise in targeting many types of cancer cells, said Dr. Sumith Kularatne, On Target's vice president of research and development.
"In addition to our current U.S. patents, we have 11 more either filed or pending in the U.S.," Kularatne said. "We have another 33 patents pending worldwide. These patents are very important in helping us move our discoveries to the public where they can help people."